Loading organizations...
Loading organizations...
Drug discovery and development for inflammatory and infectious diseases.
Blueberry Therapeutics has raised $17.1M across 2 funding rounds.
Blueberry Therapeutics has raised $17.1M in total across 2 funding rounds.
Blueberry Therapeutics has raised $17.1M in total across 2 funding rounds.
Blueberry Therapeutics's investors include Huaizheng Peng, China Medical Venture Investment, GM&C Life Sciences Fund, InClin Investments.
Blueberry Therapeutics has raised $17.1M across 2 funding rounds. Most recently, it raised $12.7M Series B in August 2018.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Aug 15, 2018 | $12.7M Series B | Huaizheng Peng, China Medical Venture Investment | |
| May 6, 2016 | $4.3M Other Equity | GM&C Life Sciences Fund | InClin Investments |